Our patient is a 39-year-old male with normal baseline blood parameters
who presented with COVID-19 infection, associated with neutropenia and
then progressed to critical disease culminating into CSS. Based on risks
and benefits evaluation, he was treated with Tocilizumab reinforced with
G-CSF leading to full recovery including reversal of neutropenia.